Profile
MAZE VRTX REGN SGEN ALNY ARGX
Company Name Maze Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $397.23M $130.72B $61.65B $43.15B $35.25B $33.73B
Employees 0.13K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
MAZE VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 4 3 1 3
Quant Rating Sell Buy Neutral Strong Sell Neutral
Trading
MAZE VRTX REGN SGEN ALNY ARGX
Last Close $9.07 $474.62 $573.45 $228.74 $235.74 $555.11
High 52 $13.43 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $9.06 $392.81 $573.37 $228.74 $143.31 $356.01
Price vs. 52 Week High -32.46 % -8.15 % -52.28 % 0 % -20.56 % -17.36 %
Price vs. 52 Week Low 0.11 % 20.83 % 0.01 % 0 % 64.5 % 55.93 %
Total Return
MAZE VRTX REGN SGEN ALNY ARGX
1 Month Return -22.87 % -2.29 % -17.95 % 0 % -4.99 % -9.48 %
3 Month Return 0 % 17.92 % -19.94 % 0 % 1.11 % -13.99 %
6 Month Return 0 % 4.24 % -43.38 % 0 % -12.03 % 4.75 %
9 Month Return 0 % 0.01 % -44.55 % 0 % -6.09 % 27.37 %
YTD Return 0 % 17.86 % -19.5 % 0 % 0.18 % -9.74 %
1 Year Return 0 % 16.71 % -39.17 % 0 % 53.52 % 43.43 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MAZE VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Profitability
MAZE VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 425.82 % 308.76 % 256.83 % 323.99 % 4929.48 %
Asset Turnover TTM 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -165.4 17.14 -141.85 -827.74 -446.48
Price To Operating Cash Flows Ratio TTM -266.09 13.96 -203.89 -4192.79 -533.11
Price Cash Flow Ratio TTM -266.09 13.96 -203.89 -4192.79 -533.11
Income Statement (TTM)
MAZE VRTX REGN SGEN ALNY ARGX
Revenue $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
MAZE VRTX REGN SGEN ALNY ARGX
Long Term Debt $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
MAZE VRTX REGN SGEN ALNY ARGX
Net Income $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B
Operating Cash Flow $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 20.95
ABCL AbCellera Biologics Inc. 2.09
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.52
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9779
ABPWW 0.044
ABSI Absci Corporation 2.28
ABUS Arbutus Biopharma Corporation 3.23
ABVC ABVC BioPharma, Inc. 0.742
ABVX Abivax SA American Depositary Shares 5.32
ACAD ACADIA Pharmaceuticals Inc. 15.38
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6387
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 1.66
ACLX Arcellx, Inc. 58.59
ETFs With Exposure to MAZE
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0032 181.19
VTI Vanguard Total Stock Market Index Fund 0 248.47
IWN iShares Russell 2000 Value ETF 0.00318 137.1
IWO iShares Russell 2000 Growth ETF 0.00374 232.32
VXF Vanguard Extended Market Index Fund 0 155.35
VTHR Vanguard Russell 3000 Index Fund 0 223.28
IWC iShares Micro-Cap ETF 0.02404 100.72
VTWV Vanguard Russell 2000 Value Index Fund 0 120.51
VTWG Vanguard Russell 2000 Growth Index Fund 0 169.34
VTWO Vanguard Russell 2000 Index Fund 0 73.19
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 84.49
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 84.48
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 44.19
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 44.18
VBINX Vanguard Balanced Index Fund Investor Shares 0 44.19
VTSAX Vanguard Total Stock Market Index Fund 0 120.94
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 117.89
VITSX Vanguard Total Stock Market Index Fund 0 120.96
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 117.9
VEMPX Vanguard Extended Market Index InstlPlus 0 290.94
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 226.91
RSSL Global X Funds 0 71.2
Unlock